Large gap with delayed quotes
|
Last quote
05/30/2026
-
02:00:00
|
Bid
05/29/2026 -
21:59:59
|
Bid Volume |
Ask
05/29/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
196.00
-0.39
(
-0.20% )
|
196.01
|
600 |
196.07
|
1,000 |
Analysis date: 26.05.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 24.04.2026.
Interest
Weak
Weak
Two stars since 22.05.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 31.12.2025 at a price of 175.99.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 21.04.2026.
4wk Rel Perf
-0.22%
-0.22%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 24.04.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.28%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.49%.
Mkt Cap in $bn
28.61
28.61
With a market capitalization >$8bn, BIOGEN is considered a large-cap stock.
G/PE Ratio
0.84
0.84
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
10.84
10.84
The estimated PE is for the year 2028.
LT Growth
9.06%
9.06%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
29
29
Over the last seven weeks, an average of 29 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
39
39
For 1% of index variation, the stock varies on average by 0.39%.
Correlation
0.12
0.12
Stock movements are totally independent of index variations.
Value at Risk
21.86
21.86
The value at risk is estimated at USD 21.86. The risk is therefore 11.32%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002